25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

Vulnerabilities Identified in Insulet Omnipod and Systech NDS-5000 Terminal Server

Advisories have been issued about recently discovered vulnerabilities in the Insulet Omnipod Insulin Management System and the Systech NDS-5000 Terminal Server.

Improper Access Control Identified in Insulet Omnipod Insulin Management System

ThirdwayV Inc. has discovered a high severity flaw in the Omnipod Insulin Management System which could allow an attacker with access to a vulnerable insulin pump to access the Pod and intercept and modify data, change insulin pump settings, and control insulin delivery.

The vulnerable insulin pumps communicate with an Insulet manufactured Personal Diabetes Manager device using wireless RF. The researchers discovered the RF communication protocol does not implement authentication or authorization properly.

The following versions are affected:

Get The FREE
HIPAA Compliance Checklist

Immediate Delivery of Checklist Link To Your Email Address

Please Enter Correct Email Address

Your Privacy Respected

HIPAA Journal Privacy Policy

  • Omnipod Insulin Management System Product ID/Reorder number: 19191 and 40160
  • UDI/Model/NDC number: ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)

The vulnerability is tracked as CVE-2020-10597 and has been assigned a CVSS v3 base score of 7.3 out of 10. There have been no reported cases of exploitation of the vulnerability.

Patients should not connect any third-party devices or use unauthorized software and should be attentive to pump notifications, alarms and alerts. Patients should monitor their blood glucose levels carefully and any unintended boluses should be cancelled at once. Insulet recommends updating to the latest model of the insulin pump, which has greater cybersecurity protections.

Patients using one of the vulnerable products have been advised to contact Insulet Customer Care or their healthcare provider for further information on the risk posed by the vulnerability.

Cross-Site Scripting Vulnerability Found in Systech NDS-5000 Terminal Server

An NDS-5000 Terminal Server cross-site scripting vulnerability has been identified that could allow an attacker to perform privileged operations on behalf of the users, access sensitive data, limit system availability, and potentially remotely execute arbitrary code. The vulnerability can be exploited remotely and requires only a low level of skill to exploit.

The vulnerability is tracked as CVE-2020-7006 and has been assigned a CVSS v3 base score of 6.8 out of 10 (medium severity). The vulnerability affects DS-5000 Terminal Server, NDS/5008 (8 Port, RJ45), firmware Version 02D.30 and has been corrected in firmware version 02F.6.

Uses of the affected product should contact Systech Technical Support for further information on updating the firmware to prevent exploitation.

The vulnerability was identified by Murat Aydemir, Critical Infrastructure Penetration Test Specialist at Biznet Bilisim A.S.

Author: Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist